Novo A/S »

Zenas Biopharma shares owned by Novo A/S

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Novo A/S

Quarter filed Position value Share count Share price at filing
2025-09-30 $44M 2.0M 22.20
2025-06-30 $22M 2.3M 9.69
2025-03-31 $18M 2.2M 7.90
2024-12-31 $13M 1.6M 8.19
2024-09-30 $20M 1.2M 16.92

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Asml Holding N V N Y Registry Shs (ASML)
Mirum Pharmaceuticals (MIRM)
Edgewise Therapeutics (EWTX)
salesforce (CRM)
Merus N V (MRUS)
Crinetics Pharmaceuticals In (CRNX)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Zenas Biopharma (ZBIO)
Pharvaris N V (PHVS)
Recursion Pharmaceuticals In Cl A (RXRX)
Arrivent Biopharma (AVBP)
BioMarin Pharmaceutical (BMRN)

View all positions for Novo A/S

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Novo A/S
Fairmount Funds Management
Federated Investors
NVP Associates
Deerfield Management Company
BlackRock
Vivo Capital
Vanguard Group
Wellington Management Company
Arrowpoint Asset Management
Pivotal bioVenture Partners Investment Advisor

View all funds holding Zenas Biopharma